ARCHIVES

Study of Dlurectic Use As Renal Cell Cancer Risk Gets Concept Approval

This article is from The Cancer Letter archive.

Vol. 15 No. 11 | March 10, 1989

Download PDF Visit The Full Archive

Related Articles

FDA Ponders Standards For “Retrospective Prospective” Studies

January 30, 2009

NCI Awards Regional CIS Contracts

August 6, 1993

NCI grants funding: Institute Contemplates Increase In RFA Support Due to Large Number Of Grant Applications

July 9, 1999

NCAB Approves 8 Cancer Centers As Comprehensive

October 4, 1991

NCI Biostatistician Calls For Reanalysis Of Canadian Breast Screening Study

February 10, 1995

Centers Form Big Ten Research Consortium with Access to Over 30,000 New Patients a Year

May 31, 2013